Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure

Journal of Perinatal Medicine

Volumn 38, Issue 4, 2010, Pages 419-423

  Chawla, Sanjay ^a   Natarajan, Girija ^a   Rane, Sharayu ^a   Thomas, Ronald ^a   Cortez, Josef ^a   Lua, Jorge ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bronchopulmonary dysplasia; intracranial hemorrhage; mortality; premature infant; steroids

Indexed keywords

BETAMETHASONE;

ADULT; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; EXTREMELY LOW BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFANT MORTALITY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERINATAL MORBIDITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ADULT; BRONCHOPULMONARY DYSPLASIA; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT MORTALITY; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; MICHIGAN; PREGNANCY; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77954584838     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.060     Document Type: Article

References (19)

1. Antenatal corticosteroids revisited: repeat courses. NIH Consens Statement. 2000;17:1-18.
2. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc. 1995;273:413-418
3. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978; 187:1-7.
4. Costa S, Zecca E, De Luca D, De Carolis MP, Romagnoli C. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Eur J Obstet Gynecol Reprod Biol. 2007;131:154-157
5. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics. 2000;106:659-671
6. Crowley P, Chalmers I, Keirse MJ. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11-25.
7. Elimian A, Figueroa R, Spitzer AR, Ogburn PL, Wiencek V, Quirk JG. Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol. 2003;102:352-355
8. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007;196:147 e1-8.
9. Ikegami M, Polk D, Jobe A. Minimum interval from fetal betamethasone treatment to postnatal lung responses in preterm lambs. Am J Obstet Gynecol. 1996;174:1408-1413 (Pubitemid 26165253)
10. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723-1729
11. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics. 1994; 93:730-736
12. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50:515-525
13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 g. J Pediatr. 1978;92:529-534
14. Pattinson RC, Makin JD, Funk M, Delport SD, Macdonald AP, Norman K, et al. The use of dexamethasone in women with preterm premature rupture of membranes - a multicentre, double-blind, placebo-controlled, randomised trial. Dexiprom Study Group. S Afr Med J. 1999;89:865-870 (Pubitemid 29495528)
15. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.
16. Sehdev HM, Abbasi S, Robertson P, Fisher L, Marchiano DA, Gerdes JS, et al. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants. Am J Obstet Gynecol. 2004;191:1409-1413
17. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. J Am Med Assoc. 2004;292:2357-2365
18. Vidaeff AC, Ramin SM, Gilstrap III LC, Alcorn JL. Characterization of corticosteroid redosing in an in vitro cell line model. Am J Obstet Gynecol. 2004;191:1403-1408
19. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: the NICHD Neonatal Research Network. Am J Obstet Gynecol. 1995;173:269-274